Sign up to save your podcasts
Or
Share TBT – The Top Papers of 2022
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
TBT – The Top Papers of 2022
Send us a text
Welcome back Rounds Table Listeners! As we approach the end of 2023, let’s revisit five important research studies from 2022: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (0:00 – 2:56) Tirzepatide Once Weekly for the Treatment of Obesity (2:56 – 6:00) Empagliflozin in Patients with Chronic Kidney Disease (6:00 – ...
The post TBT – The Top Papers of 2022 appeared first on Healthy Debate.
View all episodes
By Dr. John Fralick and Dr. Michael Fralick
5
1212 ratings
Send us a text
Welcome back Rounds Table Listeners! As we approach the end of 2023, let’s revisit five important research studies from 2022: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (0:00 – 2:56) Tirzepatide Once Weekly for the Treatment of Obesity (2:56 – 6:00) Empagliflozin in Patients with Chronic Kidney Disease (6:00 – ...
The post TBT – The Top Papers of 2022 appeared first on Healthy Debate.
More shows like The Rounds Table
View all
Hidden Brain
43,740 Listeners
NEJM This Week
319 Listeners
Emergency Medicine Cases
545 Listeners
JAMA Clinical Reviews
501 Listeners
This Week in Cardiology
891 Listeners
Under the Influence with Terry O'Reilly
787 Listeners
The Curbsiders Internal Medicine Podcast
3,372 Listeners
The Daily
112,952 Listeners
Up First from NPR
56,991 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
The Intern At Work: Internal Medicine
65 Listeners
The Peter Attia Drive
8,667 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners